“Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians.” Sanja Stanojevic, Brian L. Graham, Brendan G. Cooper, Bruce R. Thompson, Kim W. Carter, Richard W. Francis and Graham L. Hall on behalf of the Global Lung Function Initiative T LCO working group. Eur Respir J 2017; 50: 1700010.
Related content which might interest you:
“Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.” Claus F. Vogelmeier, Gerard J. Criner, Fernando J. Martinez, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Rongchang Chen, Marc Decramer, Leonardo M. Fabbri, Peter Frith, David M.G. Halpin, M. Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D. Sin, Dave Singh, Robert Stockley, Jørgen Vestbo, Jadwiga A. Wedzicha and Alvar Agusti. Eur Respir J 2017; 49: 1700214. Source: Eur Respir J, 49 (6) 1750214; 10.1183/13993003.50214-2017 Year: 2017
“2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung.” Brian L. Graham, Vito Brusasco, Felip Burgos, Brendan G. Cooper, Robert Jensen, Adrian Kendrick, Neil R. MacIntyre, Bruce R. Thompson and Jack Wanger. Eur Respir J 2017; 49: 1600016. Source: Eur Respir J, 52 (5) 1650016; 10.1183/13993003.50016-2016 Year: 2018
“Echocardiographic assessment of pulmonary hypertension: standard operating procedure.” Luke S. Howard, Julia Grapsa, David Dawson, Michael Bellamy, John B. Chambers, Navroz D. Masani, Petros Nihoyannopoulos and J. Simon R. Gibbs. Eur Respir Rev 2012; 125: 239–248. Source: Eur Respir Rev 2012 21: 370 Year: 2012
“Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort” Tom M.A. Wilkinson, Emmanuel Aris, Simon C. Bourne, Stuart C. Clarke, Mathieu Peeters, Thierry G. Pascal, Laura Taddei, Andrew C. Tuck, Viktoriya L. Kim, Kristoffer K. Ostridge, Karl J. Staples, Nicholas P. Williams, Anthony P. Williams, Stephen A. Wootton and Jeanne-Marie Devaster, on behalf of the AERIS Study Group. ERJ Open Res 2019; 5: 00248-2018. Source: ERJ Open Res, 5 (3) 00248-2018-AUT; 10.1183/23120541.50248-2018 Year: 2019
“Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing.” Denis E. O'Donnell, Amany F. Elbehairy, Azmy Faisal, Katherine A. Webb, J. Alberto Neder and Donald A. Mahler. Eur Respir Rev 2016; 25: 333–347. Source: Eur Respir Rev 2016; 25: 513 Year: 2016
“Vitamin D and skeletal muscle strength and endurance in COPD.” Abigail S. Jackson, Dinesh Shrikrishna, Julia L. Kelly, Samuel V. Kemp, Nicholas Hart, John Moxham, Michael I. Polkey, Paul Kemp and Nicholas S. Hopkinson. Eur Respir J 2013; 41: 309–316. Source: Eur Respir J 2013; 41: 998 Year: 2013
“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343–373. Source: Eur Respir J, 52 (1) 1352020; 10.1183/13993003.52020-2013 Year: 2018
“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343–373. Source: Eur Respir J 2014; 43: 1216 Year: 2014
Withdrawal notice for: “Circulating RNA differences between patients with stable and progressive lung function in IPF.” Britt Clynick, Helen E. Jo, Tamera J. Corte, Ian N. Glaspole, Christopher Grainge, Peter M.A. Hopkins, Paul N. Reynolds, Sally Chapman, E. Haydn Walters, Christopher Zappala, Gregory J. Keir, Wendy A. Cooper, Annabelle M. Mahar, Samantha Ellis, Nicole Goh, Svetlana Baltic, Marissa Ryan, Dino Tan and Yuben Moodley. Eur Respir J 2019; in press. Source: Eur Respir J, 54 (5) 1802115; 10.1183/13993003.02115-2018 Year: 2019
“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647. Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019 Year: 2020
“The effect of exacerbation history on outcomes in the IMPACT trial.” David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise and Gerard J. Criner. Eur Respir J 2020; 55: 1901921. Source: Eur Respir J, 55 (6) 1951921; 10.1183/13993003.51921-2019 Year: 2020
“2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS).” Nazzareno Galiè, Marc Humbert, Jean-Luc Vachiery, Simon Gibbs, Irene Lang, Adam Torbicki, Gérald Simonneau, Andrew Peacock, Anton Vonk Noordegraaf, Maurice Beghetti, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, Georg Hansmann, Walter Klepetko, Patrizio Lancellotti, Marco Matucci, Theresa McDonagh, Luc A. Pierard, Pedro T. Trindade, Maurizio Zompatori and Marius Hoeper. Eur Respir J 2015; 46: 903–975. Source: Eur Respir J 2015; 46: 1855-1856 Year: 2015
“Contact investigation for tuberculosis: a systematic review and meta-analysis.” Gregory J. Fox, Simone E. Barry, Warwick J. Britton and Guy B. Marks. Eur Respir J 2013; 41: 140–156. Source: Eur Respir J 2015; 46: 578 Year: 2015
“Guidelines for the management of work-related asthma.” X. Baur, T. Sigsgaard, T.B. Aasen, P.S. Burge, D. Heederik, P. Henneberger, P. Maestrelli, J. Rooyackers, V. Schlünssen, O. Vandenplas and D. Wilken on behalf of the ERS Task Force on the Management of Work-related Asthma. Eur Respir J 2012; 39: 529–545. Source: Eur Respir J 2012; 39: 1553 Year: 2012
“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057. Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018 Year: 2018
“Towards a total ban on links with the tobacco industry: new rules for the ERS.” Klaus F. Rabe, Christina Gratziou, Brian Ward and Florence Berteletti. Eur Respir J 2012; 40: 809–810. Source: Eur Respir J 2012; 40: 1307 Year: 2012
“Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.” Yael Gernez, Jeffrey Waters, Bojana Mirkovic, Gillian M. Lavelle, Colleen E. Dunn, Zoe A. Davies, Cassie Everson, Rabindra Tirouvanziam, Elana Silver, Sylvan Wallenstein, Sanjay H. Chotirmall, Noel G. McElvaney, Leonore A. Herzenberg and Richard B. Moss. Eur Respir J 2016; 47: 177–185. Source: Eur Respir J 2016; 47:1892 Year: 2016
“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230. Source: Eur Respir J, 52 (4) 1850230; 10.1183/13993003.50230-2018 Year: 2018
“Global strategy for asthma management and prevention: GINA executive summary.” E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143–178. Source: Eur Respir J, 51 (2) 0751387; 10.1183/13993003.51387-2007 Year: 2018
“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051. Source: Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019 Year: 2020